Markets · Explainer
Lilly Endowment Reports $104.21bn in LLY
Eli Lilly led the share positions in the September filing at $104.21bn.

Kunkafa News · Published · 2 min read
By Kareem FaridDiscuss with the author on X
Key points
- Lilly Endowment reported 90,066,978 shares or units of LLY on September 30.
- The leading position accounted for 100.0% of disclosed share and fund-unit value.
Lilly Endowment reported 90,066,978 shares or units of Eli Lilly, worth $104.21bn at the end of September [1].
Source: Form 13F · September 30, 2026 · USD millions
The reported Eli Lilly position fell from 90,376,978 shares or units in June to 90,066,978 in September, a change of 0.3% [1] [2].
Form 13F records quarter-end positions. Changes in reported value reflect market prices as well as changes in the number of shares. The filing does not show trade dates or short stock positions [1].
June 30September 30
Source: Forms 13F · June 30 and September 30, 2026 · shares or fund units
| Security | June 30 units | Sept. 30 units | Sept. USD millions |
|---|---|---|---|
| LLY | 90,376,978 | 90,066,978 | 104,214.698 |
Sources: Form 13F · June and September 2026.
Sources: [1] 13F-HR · 2026-10-19 · [2] 13F-HR · 2026-07-23
Kunkafa forecasts
S&P 500 Index
How far it could move, which way, by when, and how confident Kunkafa is.
Check the latest forecastsMore in Markets

CalSTRS Reports $7.88bn in NVDA
Nvidia led the share positions in the September filing at $7.88bn.

Schroder Holds More IBN, Less TPR
The IBN position grew 169.4% by share count, while the TPR position fell 55.7% between June and September.

Baillie Gifford & Co Holds More LRCX, Less SPCX
The LRCX position grew 6,028,782.8% by share count, while the SPCX position fell 24.1% between June and September.